Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 2.715
+0.060 (2.26%)
At close: Mar 20, 2026
Nyxoah Employees
Nyxoah had 184 employees as of December 31, 2024. The number of employees increased by 37 or 25.07% compared to the previous year.
Employees
184
Change (1Y)
37
Growth (1Y)
25.07%
Revenue / Employee
€54,457
Profits / Employee
€489,592
Market Cap
116.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 184 | 37 | 25.07% |
| Dec 31, 2023 | 147 | 9 | 6.76% |
| Dec 31, 2022 | 138 | 32 | 29.96% |
| Dec 31, 2021 | 106 | 34 | 47.15% |
| Mar 31, 2021 | 79 | 36 | 84.71% |
| Dec 31, 2020 | 72 | 29 | 69.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,765 |
| Fagron NV | 4,193 |
| Ion Beam Applications | 2,100 |
| argenx SE | 1,599 |
| European Medical Solutions | 123 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 50 |
| Sequana Medical NV | 48 |
Nyxoah News
- 4 weeks ago - Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - GlobeNewsWire
- 2 months ago - Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewsWire
- 2 months ago - Publication relating to transparency notification - GlobeNewsWire
- 3 months ago - Nyxoah Announces Issuance of First Tranche of Convertible Bonds - GlobeNewsWire
- 3 months ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands - GlobeNewsWire
- 3 months ago - Publication relating to transparency notifications - GlobeNewsWire
- 4 months ago - Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - GlobeNewsWire